BMI (kg/m2) | 18.5–22.4 | 22.5–24.9 | 25.0–27.4 | 27.5–29.9 | 30.0–39.9 |
N=721 | N=1804 | N=1938 | N=1038 | N=581 | |
HR (95% CI) | HR (95% CI) | referent | HR (95% CI) | HR (95% CI) | |
CHD events | |||||
Events, n (%) | 136 (18.9) | 351 (19.5) | 381 (19.7) | 232 (22.4) | 141 (24.3) |
Model 1 | 0.97 (0.79 to 1.18) | 1.00 (0.87 to 1.15) | 1.0 | 1.18 (1.00 to 1.39) | 1.29 (1.07 to 1.57) |
Model 2 | 1.06 (0.87 to 1.30) | 1.04 (0.89 to 1.20) | 1.0 | 1.08 (0.92 to 1.27) | 1.14 (0.94 to 1.39) |
Non-fatal CHD | |||||
Events, n (%) | 110 (15.3) | 293 (16.2) | 324 (16.7) | 188 (18.1) | 112 (19.3) |
Model 1 | 0.93 (0.75 to 1.15) | 0.98 (0.84 to 1.15) | 1.0 | 1.13 (0.94 to 1.35) | 1.21 (0.97 to 1.50) |
Model 2 | 1.04 (0.84 to 1.30) | 1.03 (0.88 to 1.21) | 1.0 | 1.03 (0.86 to 1.23) | 1.06 (0.86 to 1.32) |
Fatal CHD | |||||
Events, n (%) | 26 (3.6) | 58 (3.2) | 57 (2.9) | 44 (4.2) | 29 (5.0) |
Model 1 | 1.20 (0.76 to 1.91) | 1.10 (0.77 to 1.59) | 1.0 | 1.47 (0.99 to 2.18) | 1.75 (1.12 to 2.74) |
Model 2 | 1.18 (0.74 to 1.90) | 1.08 (0.74 to 1.56) | 1.0 | 1.37 (0.92 to 2.04) | 1.60 (1.02 to 2.53) |
Model 1: adjusted for randomised treatment and age.
Model 2: adjusted for smoking, BP, hypertension, cholesterol (HDL and LDL), triglycerides, nitrates use, history of angina, social deprivation score (DEPCAT), various drugs (aspirin, ACE inhibitors, β blockers, calcium channel blockers, diuretics, other).
BMI, body mass index; BP, blood pressure; CHD, coronary heart disease; DEPCAT, deprivation category; HDL, high-density lipoprotein; LDL, low-density lipoprotein.